Eton Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $10,324 | $9,074 | $7,966 | $7,313 |
Gross Profit | 6,302 | 5,626 | 5,007 | 3,630 |
EBITDA | 509 | -2,656 | -548 | -1,717 |
EBIT | -2,935 | -800 | -1,992 | |
Net Income | 627 | -3,041 | -811 | -2,256 |
Net Change In Cash | 10,324 | 9,074 | 7,966 | 7,313 |
Free Cash Flow | 4,820 | 1,255 | -4,355 | -388 |
Cash | 20,261 | 17,694 | 16,655 | 21,388 |
Basic Shares | 26,550 | 25,778 | 25,763 | 25,741 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $31,642 | $21,251 | $21,832 | $39 |
Gross Profit | 21,061 | 14,318 | 19,209 | -247 |
EBITDA | -291 | -6,486 | -1,121 | -26,460 |
EBIT | -1,192 | -8,251 | -1,568 | -27,111 |
Net Income | -936 | -9,782 | -2,961 | -28,829 |
Net Change In Cash | 31,642 | 21,251 | 21,832 | 39 |
Cost of Revenue | 1,899 | 9,229 | ||
Free Cash Flow | 6,040 | 2,033 | -7,980 | -22,396 |
Cash | 21,388 | 16,305 | 14,406 | 21,295 |
Basic Shares | 25,645 | 25,146 | 25,207 | 21,010 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.02 |
2024-06-30 | -$0.12 |
2024-03-31 | -$0.03 |
2023-12-31 | -$0.09 |
